A pipeline for testing drug mechanism of action and combination therapies: from microarray data to simulations via linear-in-flux-expressions. Testing four-drug combinations for tuberculosis treatment
From MaRDI portal
Publication:6133977
Recommendations
- Metabolic graphs, the LIFE method, and modeling drug action on \textit{Mycobacterium tuberculosis}
- Mathematical modeling of pulmonary tuberculosis therapy: insights from a prototype model with rifampin
- Mathematical modeling and systems pharmacology of tuberculosis: isoniazid as a case study
- A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment
- MATHEMATICAL MODELING OF CHEMOTHERAPY OF HUMAN TB INFECTION
Cites work
- Asymptotic behavior of nonlinear compartmental systems: Nonoscillation and stability
- Hypergraph theory. An introduction
- Introduction to graph and hypergraph theory
- Metabolic graphs, the LIFE method, and modeling drug action on \textit{Mycobacterium tuberculosis}
- Qualitative Theory of Compartmental Systems
- Stability of metabolic networks via linear-in-flux-expressions
Cited in
(4)- Algorithms and methodological challenges in the development and application of quantitative systems pharmacology models: a case study in type 2 diabetes
- A novel ensemble based recommendation approach using network based analysis for identification of effective drugs for tuberculosis
- Applying quantitative systems pharmacology (QSP) modeling to understand the treatment of \textit{Pneumocystis}
- Metabolic graphs, the LIFE method, and modeling drug action on \textit{Mycobacterium tuberculosis}
This page was built for publication: A pipeline for testing drug mechanism of action and combination therapies: from microarray data to simulations via linear-in-flux-expressions. Testing four-drug combinations for tuberculosis treatment
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6133977)